Director/PDMR Shareholding

1

Issuer

Oxford BioMedica PLC

2

Reason for notification

Notification relates to DTR 3.1.2R

3

Name of PDMR

Martin Diggle

4

Connected person

Notification relates to following connected persons:

Vulpes Life Sciences Fund

5

Notification in respect of

Notification in respect of holdings of persons in 4 above

6

Description of shares

Oxford BioMedica PLC ordinary shares of 1p each

7

Name of registered shareholders and number of shares

Vulpes Life Sciences Fund - 549,132,000 shares

Vulpes Testudo Fund - 33,333,333 shares

8

Nature of transaction

Acquisition

9

Number of shares acquired

Vulpes Life Sciences Fund - 600,000 shares

10

Percentage of issued class acquired

Vulpes Life Sciences Fund - 0.02%

11

Shares disposed

N/A

12

Percentage of issued class disposed

N/A

13/14

Price per share of transactions, and date

Vulpes Life Sciences Fund

600,000 shares @ £0.0422 , 23 Jan 2017

15

Total holding following notification and total percentage holding following notification

Vulpes Life Sciences Fund - 549,732,000 shares

17.80%

Vulpes Testudo Fund - 33,333,333 shares

1.08%

16

Date issuer informed

24 Jan 2017

23

Any additional information

None

24

Contact name and telephone number

T. Watts, Chief Financial Officer

Oxford BioMedica

+44 (0)1865 783000